Enrollment Completed for Clinical Trial of a Suprachoroidal Microstent

Enrollment has been completed for the COMPASS clinical study evaluating the CyPass Micro-Stent (Transcend Medical, Inc.) in combination with cataract surgery for patients with primary open-angle glaucoma, according to a news release. “This is an important milestone in the field of glaucoma,” Steven Vold, MD, found...

Full Story →